Literature DB >> 3342806

Superoxide dismutase activity in renal cell carcinoma.

T Nakada1, T Akiya, H Koike, T Katayama.   

Abstract

Both Cu-Zn- and Mn-superoxide dismutase (SOD) activities were determined in renal cell carcinoma and tumor-uninvolved renal tissues in 25 patients with renal cancer. These enzymatic activities were similar in tumor and tumor-uninvolved renal tissues. The age of the patients, grade or stage of tumors had no apparent effect on SOD activities. Renal arterial embolization caused a slight decrease (p less than 0.05) in Cu-Zn-SOD activity in tumor tissues, but none in other enzymes in the same tissues, while renal arterial embolization reduced each SOD activity in tumor-uninvolved renal tissues (p less than 0.01 - p less than 0.001). Therefore the development of renal cell carcinoma is probably not related to the abnormality of renal SOD, but renal ischemic changes appear to lower each SOD activity in normal renal tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342806     DOI: 10.1159/000472897

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Activities of superoxide dismutase and glutathione peroxidase enzymes in cancerous and non-cancerous human kidney tissues.

Authors:  I Durak; Y Bedük; M Kavutcu; S Oztürk; O Canbolat; S Ulutepe
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

2.  Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.

Authors:  Necip Pirinççi; Tacettin Yekta Kaya; Mehmet Kaba; Tunç Ozan; İlhan Geçit; Hüseyin Özveren; Hüseyin Eren; Kadir Ceylan
Journal:  Redox Rep       Date:  2016-07-14       Impact factor: 4.412

3.  Impaired enzymatic antioxidant defense mechanism in cancerous human thyroid tissues.

Authors:  I Durak; F Bayram; M Kavutcu; O Canbolat; H S Oztürk
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

4.  Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.

Authors:  Necip Pirinççi; Ilhan Geçit; Mustafa Güneş; Mehmet Bilgehan Yüksel; Mehmet Kaba; Serhat Tanık; Halit Demir; Mehmet Aslan
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.